OBJECTIVE To compare the clinical manifestations observed in AIDS patients infected with HIV2 and HIV1 infection. METHODS The medical records of AIDS patients hospitalized between January 1986 and July 1997 at the Department of Infectious Diseases of Fann Hospital, Dakar, were reviewed. RESULTS 599 hospitalizations (76%) were HIV1 seropositive patients, 137 (17%) were HIV2 seropositive patients and 54 (7%) were patients serologically dually reactive to HIV1 and HIV2. There was no significant difference in medium CD 4 lymphocyte count between patients with HIV1 and HIV2 infection. Chronic diarrhoea and diarrhoea caused by bacterial infections were more frequently observed in HIV2-infected individuals. Oral candidiasis and chronic fever were more often noted in patients with HIV1 infection. Bacterial and cryptococcal meningitis was only observed among patients with HIV1 infection.
Introduction
The clinical spectrum associated with HIV1 infection is well known and has been described in many developing countries (Colebunders & Latif 1991; Gilks 1993) . On the other hand there are only a limited number of studies concerning the natural history and the clinical manifestations associated with HIV2 infection (Schim van der Loeff & Aaby 1999). HIV2 is less infectious (Koffi et al. 1992; Poulsen et al. 1992 Poulsen et al. , 1993 Kanki & De Cock 1994; ) than HIV1 and progresses more slowly towards disease (Pepin et al. 1991; Marlink et al. 1994; Whittle et al. 1994; Norrgren et al. 1995) . Patients with HIV2 infection also may develop AIDS, and it is important to know whether they have different clinical manifestations/opportunistic infections/malignancies than patients with HIV1 infection. If AIDS caused by HIV2 infection is different from AIDS caused by HIV1 infection, this may have implications for patient management strategies.
Data collected so far among hospitalized AIDS patients suggest that AIDS patients with HIV2 and HIV1 infection present with similar clinical manifestations (Clavel et al. 1987; De Cock et al. 1990; Le Guenno et al. 1991; Naucler et al. 1991) . In an autopsy study from Abidjan, 93% of HIV2-positive individuals died of an HIV-related disease and there was no detectable difference in pathology between HIV1 and HIV2 patients, except that severe multiorgan cytomegalovirus (CMV) infection, HIV encephalitis and cholangitis were all significantly more frequent in HIV2-infected persons (Lucas et al. 1993) . The explanation of this finding is unclear, but it has been suggested that persons with TMIH627 HIV2 infection developed these conditions more frequently than those with HIV1 infection because they survived longer in the terminal stage of their disease. In another study in Abidjan, HIV2-positive patients with tuberculosis had similar abnormalities on chest X-rays as HIV1-positive patients, but were less likely to have extrapulmonary disease (Gnaore et al. 1993; Abouya et al. 1995) . The very limited data available so far show little difference in the CD4 lymphocyte count at which severe opportunistic infections occur between persons with HIV1 compared with HIV2 infection (Naucler et al. 1992; Grand et al. 1997) .
HIV2 infection is mainly prevalent in West Africa. In Ivory Coast, however, the majority of the AIDS patients are either HIV1 seropositive or they present with a dual reaction to HIV1 and HIV2 (De Cock et al. 1990) . Therefore it is difficult in this country to compare the clinical manifestations associated with HIV2 infection with those associated with HIV1 infection. On the other hand, in Guinea-Bissau (Lisse et al. 1990; Ricard et al. 1994) and The Gambia (Whittle et al. 1994 ) most patients are infected with HIV2. Only in Senegal are both HIV1 and HIV2 prevalent (De Cock & Brun-Vézinet 1991; Kanki & De Cock 1994) . Most AIDS patients in Dakar are hospitalized in the Department of Infectious Diseases of Fann Hospital. Since January 1986 this hospital has a surveillance system for AIDS (Sow et al. 1994) . We used this system to describe the clinical manifestations associated with HIV1 and HIV2 infection.
Methods
The medical records of AIDS patients hospitalized at the Department of Infectious Diseases of Fann Hospital in Dakar were reviewed using a standardized questionnaire to record symptoms/signs present upon hospitalization and infections/ malignancies diagnosed during stationary care. All records from patients hospitalized between January 1986 and July 1997 were reviewed. If a patient was hospitalized more than once, clinical manifestations at each hospitalization were recorded.
Patients were included in the study when they met the clinical AIDS case definition criteria of the World Health Organization (WHO) (Colebunders et al. 1987) and when they had an HIV-positive ELISA (enzyme-linked immunosorbent assay) test confirmed by Western blot.
HIV serology was performed using the ELISA, ELAVIA1 and ELAVIA2 Pasteur for the screening of patients. Positive samples were confirmed by Western Blot (LAVBLOT1 and LAVBLOT2, Pasteur Diagnostics). Patients with indeterminate serological results were considered seronegative. Patients considered in a first phase to be seropositive for HIV1 and HIV2 (because their antibodies recognized the glycoproteins of the envelope of both viruses) were then tested with peptides (Pepti-LAV Pasteur) and classified as HIV1, HIV2 or dually infected.
During the study period the following laboratory tests were available: blood, urine and stool cultures on standard culture media, direct sputum smear examination by Ziehl-Neelsen, culture of expectorations, pleural and broncho-alveolar fluid on Löwenstein-Jensen medium, direct parasitological stool examination, examination of cerebrospinal fluid for cryptococci using Indian ink and culture on Sabouraud medium. Chest X-rays were taken of most patients, but only in a limited number with pulmonary infiltrates of unknown origin underwent broncho-alveolar lavage. In case of neurological manifestations, a CT scan of the brain was performed in a limited number of patients only. Lymphocyte subsets were determined by flow cytometry (FACSCAN, BectonDickinson).
Definitions
A patient was considered to present with wasting syndrome when he/she had lost 10% body weight and presented with diarrhoea or fever of more than 1 month duration. Tuberculosis was diagnosed when the Ziehl-Neelsen smear was positive, sputum culture grew mycobacteria, when there were pleural effusions with predominance of lymphocytes in the pleural fluid, when the patient responded to antituberculous treatment or presented with chest X-ray findings suggesting milliary tuberculosis. Septicaemia was diagnosed when a clinical pathogen was isolated from one or more blood cultures. Interstitial pneumopathia was diagnosed when a chest X-ray showed an interstitial infiltrate of both lungs in a patient with a cough of unknown origin.
A patient was considered to have bacterial pneumonia when he/she had clinical signs of pneumonia, a chest X-ray showing a pulmonary infiltrate, and a positive blood culture, or if a patient with clinical signs of pneumonia responded well to a nontuberculous antibiotic treatment. Pneumonia patients with a positive blood culture were also included as septicaemia patients. Bacterial enteritis was diagnosed when a bacterial pathogen was found in the stools of a patient with diarrhoea. Cerebral toxoplasmosis was diagnosed on the basis of suggestive CT scan findings of the brain, or if a patient with neurological symptoms responded favourably to specific antitoxoplasmosis treatment. Bacterial meningitis was diagnosed if a pathogen was identified in the cerebrospinal fluid (direct examination or culture) or if there were more than 100 leucocytes/µl in the cerebrospinal fluid. Candida oesophagitis was diagnosed in the presence of oral candidiasis and dysphagia. Prurigo was defined as a chronic generalized papulo-pruritic eruption of unknown origin. Post-mortem examinations were not performed.
Statistical methods
Statistical analysis was performed using Epi-Info version 6.0 and Intercooled-Stata. Continuous variables were compared using Student's t-test for normally distributed variables and the Kruskal-Wallis test for variables not normally distributed. Categorical variables were compared using the chisquare test or Fisher's exact test as appropriate.
Results
Between January 1986 and July 1997, the Department of Infectious Diseases of Fann Hospital admitted 790 patients with AIDS. 624 (79%) patients with AIDS were hospitalized only once, 166 (21%) were hospitalized at least twice. All patients were diagnosed with HIV upon their first hospitalization. None of those who were hospitalized more than once had received prophylaxis for opportunistic infections. During the study period there were no important changes in health services for AIDS patients, apart from in 1992, when the infectious disease ward had temporarily not been functioning due to renovation. In 63 (8%) cases hardly any work-up was done because they died rapidly or laboratory tests could not be performed. CD 4 lymphocyte counts were obtained for 127 (17.5%) patients.
The number of hospitalized AIDS patients increased progressively between 1986 and 1991 (Table 1 ). In July 1992 only a few AIDS patients were admitted because the ward was hardly functioning. In 1993 the ward was restarted and saw a progressive increase in numbers of AIDS patients admitted between 1993 and 1997. Between 1986 and 1997 the percentage of patients with HIV1 infection increased, while the percentage of patients dually reactive to HIV1 and HIV2 remained low (between 0 and 14%).
Patient characteristics
599 hospitalizations (76%) were HIV1-seropositive patients, 137 (17%) were HIV2-seropositive patients and 54 (7%) were dually infected patients. Most (69%) were men and presented with severe immune deficiency: 75% had a CD 4 lymphocyte count < 200/mm 3 . There was no significant difference in median CD 4 lymphocyte count between patients with HIV1 and HIV2 infection ( Table 2 ). The mean duration of hospitalization was 23 days.
Comparison of the clinical manifestations associated with HIV1 and HIV2 infection
Chronic diarrhoea and diarrhoea caused by bacterial infections were more frequently observed among persons with HIV2 infection (Tables 3 and 4) . On the other hand oral candidiasis and chronic fever were more often noted in patients with HIV1 infection. Patients with HIV1 and HIV2 infection more often presented with polyneuritis compared with patients dually reactive to HIV1 and HIV2. Bacterial and cryptococcal meningitis was only observed among patients with HIV1 infection. Prurigo was mainly observed in patients dually reactive for HIV1 and HIV2 infection. Mortality during hospitalization was very high: 261 (44%) patients with HIV1 infection, 54 (40%) patients with HIV2 infection and 27 (50%) patients dually reactive to HIV1 and HIV2 died during hospitalization. 
Discussion
The number of AIDS cases hospitalized at Fann Hospital has increased progressively since 1986. Despite the fact that HIV2 infection remains more prevalent in Senegal (Kanki & De Cock 1994 ) than HIV1 infection among asymptomatic individuals, most patients with AIDS were infected with HIV1. In Dakar over the years the percentage of AIDS patients with HIV1 infection has increased, as has been the case in other West-African countries (Koffi et al. 1992) . The explanation of this phenomenon is that HIV1 is more infectious and more pathogenic than HIV2 (Le Guenno et al. 1991) . While the overall HIV seroprevalence among pregnant women in Dakar has remained stable over the years at about 1% (PNLS 1998), the incidence of HIV1 infection among commercial sex workers has increased ; Schim van der Loeff & Aaby 1999), implying that the percentage of AIDS patients with HIV1 infection will further increase in Senegal.
The percentage of AIDS patients with dual reactivity to HIV1 and HIV2 has remained low (< 7%) and relatively stable since 1986. This contrasts with Ivory Coast and Mali, where the prevalence of dual reactivity has increased Peeters et al. 1992) . Why this is so remains unclear. It could be related to different laboratory techniques used to diagnose HIV1 and HIV2 infection, to the fact that an HIV2 infection protects an individual against an HIV1 infection, (Travers et al. 1995) or because HIV2 and HIV1 infection were introduced at different time periods. In Senegal HIV2 infection was introduced before HIV1 infection. In Ivory Coast both infections were probably introduced at the same time.
The clinical manifestations observed among AIDS patients in Dakar were similar to those observed in other African countries. Septicaemias were less often reported in Dakar than in other series of African AIDS patients (Gilks et al. 1990; Taelman et al. 1990; Grand et al. 1997) , but this is probably because at Fann Hospital blood cultures were not systematically performed. Cerebral toxoplasmosis was probably underdiagnosed in Dakar. Many AIDS patients presented with a focal neurological deficit and/or encephalitis but only three were treated for cerebral toxoplasmosis.
There were certain clinical differences between HIV1 and HIV2 patients. Chronic diarrhoea and diarrhoea caused by bacterial infections were more frequent in persons with HIV2 infection. Oral candidiasis and chronic fever were more often noted in patients with HIV1 infection. These differences have never been reported before. In an autopsy study performed in Abidjan only multiorgan CMV infections, HIV encephalitis and cholangitis were more frequently found in persons with HIV2 infection (Lucas et al. 1993) . Lack of diagnostic capacities and treatment options do not account for these *Patients with HIV1 infection were 1.53 more likely to have fever (P ϭ 0.04), 1,46 times more likely to have oral candidiasis (P ϭ 0.05) and half less likely to have diarrhoea compared to patients with HIV2 infection (P ϭ 0.03). **Patients with HIV1 infection were 6 times more likely to have polyneuritis (P ϭ 0.04) and were appoximately half less likely to have prurigo (P ϭ 0.01) compared to patients with HIV1-2 infection. ***Patients with HIV2 infection were almost 10 times more likely to have polyneuritis (P ϭ 0.009) and were one third less likely to have prurigo (P ϭ 0.003) compared to people with HIV1-2 infection. differences, because they affected all patients. Possibly the differences only appeared by chance because so many clinical variables were compared. As there is no clear physiopathological explanation, a larger number of AIDS patients with HIV1 and HIV2 infection should be studied in order to determine whether the differences are real. To do so we propose to organize a multicentre study in different West-African countries using a similar methodology.
